Loading dashboard...
Peptide Assistant
Online
AI can make mistakes. Verify important medical data.
Press Enter to send
G
Medical Engine
Guest Account
AI can make mistakes. Verify important medical data.
Press Enter to send
Medical Engine
Guest Account
Loading dashboard...
The Seesaw Protocol: Balancing immunity by repairing the barrier.
The Analogy: Your gut lining is the Castle Wall protecting your bloodstream from the barbarians (bacteria/food particles) in your stomach.
| Agent | Role | Dose |
|---|---|---|
| BPC-157 (Oral) | Structural Repair | 500mcg twice daily (AM/PM) |
| KPV (Oral/Spray) | Anti-Inflammatory | 200mcg daily |
| Larazotide (Advanced) | Tight Junction Zipper | 1mg with meals (if available) |
Use this interactive flowchart to quickly pick a starting protocol (then jump to the right chapter and tools).
Pick your primary gut issue and get a starting stack + next best action.
A: No. While injectable BPC is systemic, Oral BPC-157 (Arg-Salt) is superior for gut issues because it directly coats the site of injury (gastric mucosa) on the way down.
A: Spray is better for sinus/systemic issues (Mold). Capsules are better for lower GI issues (Crohn's/Colitis) as they reach the colon.
29yo Female, Moderate flare. Mayo Score 8/12. Failed mesalamine and budesonide.
Bowel movements reduced from 8/day to 4/day
50% reduction in frequency
Abdominal pain reduced by 80%
Significant pain relief
Colonoscopy showed significant mucosal healing
Structural improvement confirmed
Mayo Score 1/12 (clinical remission)
Complete remission achieved
Gastroenterologist's assessment: 'This peptide combination provided steroid-level efficacy without the side effects.'
42yo Female. High TPO antibodies (>1300 IU/mL). Fatigue and brain fog despite Synthroid.
TPO >1300. CRP 4.2. Severe fatigue.
Active flare
Added LDN (4.5mg) + Thymosin Alpha-1 (1.5mg 2x/wk). Fatigue improved.
Immune modulation started
TPO antibodies dropped to 450 IU/mL. CRP 0.8.
65% reduction in autoimmunity
Subject reported 'feeling like herself again' for the first time in 5 years. Antibodies continued to downtrend.
35yo Male. 3 rounds of Rifaximin failed. Bloating immediately after meals.
LL-37 (Low Dose) + BPC-157 (Oral) + Motility Agent
Antimicrobial + Repair
Die-off symptoms subsided. Bloating reduced 50%.
Bacterial load reducing
Breath test negative for methane and hydrogen.
SIBO Eradicated
Maintenance with oral BPC-157 prevented relapse (which usually occurred at month 3).